US sells Wu-Tang Clan al­bum to cov­er Shkre­li debt; Or­biMed backs GSK vet­s' Chi­nese start­up

Mar­tin Shkre­li be­came a top tar­get for ridicule and anger in the mid-2010s when he and his biotech Tur­ing Phar­ma­ceu­ti­cals raised the price of a life-sav­ing med­i­cine from $13.50 to $750 per pill. But he al­so gained no­to­ri­ety around that time for pur­chas­ing a one-of-a-kind al­bum from rap group the Wu-Tang Clan at auc­tion for about $2 mil­lion.

Now, the al­bum is on the move again.

The De­part­ment of Jus­tice an­nounced Tues­day it has sold the al­bum, “Once Up­on a Time in Shaolin,” to an undis­closed buy­er to help cov­er Shkre­li’s $7.36 mil­lion debt when he was con­vict­ed for de­fraud­ing in­vestors in 2017. The sale of the al­bum ac­count­ed for the re­main­der of Shkre­li’s bal­ance, the de­part­ment said in a news re­lease.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN